Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

US Patent 12337002 · Granted Jun 24, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral rifamycin SV compositions2024
Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,2024
Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,2024
Oral rifamycin SV compositions2023
Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-d2021
Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-d2021
Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or en2021
Liquid composition in the form of emulsion or microemulsion for rectal administr2021
Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or en2020
Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,2020
Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,2020
Controlled release and taste masking oral pharmaceutical composition2020